Skip to main content
SpringerLink
Log in

Angiogenesis and Angiogenic Factors of Gastric Cancer

  • Chapter
Book cover Multimodality Therapy for Gastric Cancer

  • 98 Accesses

Abstract

Gastric cancer prognosis depends on the pathologic tumor type and the stage of disease [1,2]. Intestinal-type gastric cancer tends to be exophytic, metastasizing to the liver by hematogenous dissemination. In contrast, diffuse-type gastric cancer is more invasive, with predominantly peritoneal dissemination. The factors responsible for liver metastasis and peritoneal dissemination have not yet been identified.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Nishi M, Tamura T (1962) Clinical study of stomach cancer with hepatic metastasis. Jpn J Cancer Clin 8:422–433 (in Japanese)

    Google Scholar 

  2. Duarte I, Llanos O (1981) Patterns of metastases in intestinal and diffuse types of carcinoma of the stomach. Hum Pathol 12:237–242

    Article  PubMed  CAS  Google Scholar 

  3. Folkman J (1986) How is blood vessel growth regulated in normal and neoplastic tissue? G. H. A. Clowes memorial award lecture. Cancer Res 46:467–473

    PubMed  CAS  Google Scholar 

  4. Liotta L, Kleinerman J, Saldel G (1974) Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 34:997–1004

    PubMed  CAS  Google Scholar 

  5. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 324:1–8

    Article  PubMed  CAS  Google Scholar 

  6. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA (1992) Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet 340:145–146

    Article  PubMed  CAS  Google Scholar 

  7. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J (1993) Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143:401–409

    PubMed  CAS  Google Scholar 

  8. Graham CH, Rivers J, Kerbel RS, Stankiewicz KS, White WL (1994) Extent of vascularization as a prognostic indicator in thin (<0.76mm) malignant melanomas. Am J Pathol 145:510–514

    PubMed  CAS  Google Scholar 

  9. Smith-McCune KK, Weidner N (1994) Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res 54:800–804

    PubMed  CAS  Google Scholar 

  10. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM (1995) Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55:3964–3968

    PubMed  CAS  Google Scholar 

  11. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306

    Article  PubMed  CAS  Google Scholar 

  12. Ferrara N, Houck K, Jakeman L, Leung DW (1992) Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13:18–32

    PubMed  CAS  Google Scholar 

  13. Folkman J, Klagsbrun M (1987) Angiogenic factors. Science 235:442–447

    Article  PubMed  CAS  Google Scholar 

  14. New B, Yeoman L (1992) Identification of basic fibroblast growth factor sensitivity and receptor and ligand expression in human colon tumor cell lines. Cell Physiol 150:320–326

    Article  CAS  Google Scholar 

  15. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR, Dvorak HF (1993) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 53:4727–4735

    PubMed  CAS  Google Scholar 

  16. Millauer B, Wizigmann-Voos S, Achnurch H, Martinez R, Moller NPH, Risau W, Ullrich A (1993) High affinity VEGF binding and developmental expression suggest KDR as a major regulator of vasculogenesis and angiogenesis. Cell 72:835–846

    Article  PubMed  CAS  Google Scholar 

  17. Brown LF, Berse B, Jackman RW, Tognazzi K, Guidi AJ, Dvorak HF, Senger DR, Connolly JL, Schnitt SJ (1995) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 26:86–91

    Article  PubMed  CAS  Google Scholar 

  18. Samoto K, Ikezaki K, Ono M, Shono T, Kohno K, Kuwano M, Fukui M (1995) Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res 55:1189–1193

    PubMed  CAS  Google Scholar 

  19. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM (1995) Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55:3964–3968

    PubMed  CAS  Google Scholar 

  20. Kitadai Y, Ellis LM, Takahashi Y, Bucana CD, Anzai H, Tahara E, Fidler IJ (1995) Mutiparametric in situ messenger RNA hybridization analysis to detect metastasis-related genes in surgical specimens of human colon carcinomas. Clin Cancer Res 1:1095–1102

    PubMed  CAS  Google Scholar 

  21. Takahashi Y, Tucker SL, Kitadai Y, Koura AN, Bucana CD, Cleary KR, Ellis LM (1997) Vessel counts and VEGF expression as prognostic factors in node-negative colon cancer. Arch Surg 132:541–546

    Article  PubMed  CAS  Google Scholar 

  22. Takahashi Y, Cleary KR, Mai M, Kitadai Y, Bucana CD, Ellis LM (1996) Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin Cancer Res 2:1679–1684

    PubMed  CAS  Google Scholar 

  23. Miyazono K, Okabe T, Urabe A, Takaku F, Heldin C-H (1987) Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem 262:4008–4103

    Google Scholar 

  24. Ishikawa F, Miyazono K, Hellman U, Drexler H, Wemstedt C, Hagiwara I, Usuki K, Takaku F, Risau W, Heldin CH (1989) Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338:557–562

    Article  PubMed  CAS  Google Scholar 

  25. Moghaddam A, Bicknell R (1992) Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine Phosphorylase activity. Biochemistry 31:12141–12146

    Article  PubMed  CAS  Google Scholar 

  26. Zimmerman M, Seidenberg J (1964) Deoxyribosyl transfer. 1. Thymidine Phosphorylase and nucleoside deoxyribosyltransferase in normal and malignant tissues. J Biol Chem 239:2618–2621

    PubMed  CAS  Google Scholar 

  27. Pauly JL, Schuller MG, Zelcer AA, Kirss TA, Gore SS, Germain MJ (1977) Identification and comparative analysis of thymidine Phosphorylase in the plasma of healthy subjects and cancer patients. J Natl Cancer Inst 58:1587–1590

    PubMed  CAS  Google Scholar 

  28. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, Leonard EJ (1987) Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 84:9233–9237

    Article  PubMed  CAS  Google Scholar 

  29. Reynolds K, Frazaneh F, Collins WP, Campbell S, Bourne TH, Lawton F, Moghaddam A, Harris AL, Bicknell R (1994) Correlation of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J Natl Cancer Inst 86:1234–1238

    Article  PubMed  CAS  Google Scholar 

  30. O’Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL (1995) Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res 55:510–513

    CAS  Google Scholar 

  31. Baird A, Momede P, Bohlen P (1985) Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor. Biochem Biophys Res Commun 126:358–364

    Article  PubMed  CAS  Google Scholar 

  32. Madtes DK, Raines EW, Sakariassen KS, Assoian RK, Sporn MB, Bell GI (1988) Imduction of transforming growth factor-α in activated human alveolar macrophages. Cell 53:285–293

    Article  PubMed  CAS  Google Scholar 

  33. Martinet Y, Bitterman PB, Mornex J-F, Grotendorst GR, Martin GR, Crystal RG (1986) Activated human monocytes express the c-sis proto-oncogene and release a mediator showing pdgf-like activity. Nature 319:158–160

    Article  PubMed  CAS  Google Scholar 

  34. Berse B, Brown LF, van DeWater L, Dvorak HA, Senger DR (1992) Vascular permeability factor (vascular endothelial growth factor) is expressed differentially m normal tissues, macrophages, and tumors. Mol Biol Cell 3:211–220

    PubMed  CAS  Google Scholar 

  35. Polverini PJ, Leibovich SJ (1984) Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab Invest 51:635–642

    PubMed  CAS  Google Scholar 

  36. Leibovich S, Polverini P, Shepard H, Wiseman D, Shively V, Nuseir N (1987) Macrophage-induced angiogenesis is mediated b tumor necrosis factor-α. Nature 329:630–632

    Article  PubMed  CAS  Google Scholar 

  37. Griffiths L, Dachs GU, Bicknell R, Harris AL, Stratford IJ (1997) The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphoryl in human breast tumor cells grown in vitro and in vivo. Cancer Res 57:570–572

    PubMed  CAS  Google Scholar 

  38. Levy AP, Levy NS, Wegner S, Goldberg MA (1995) Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 270:13333–13340

    Article  PubMed  CAS  Google Scholar 

  39. Liu Y, Cox SR, Morita T, Kourembanas S (1995) Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells: idenification of a 5′ enhancer. Circ Res 77:638–643

    Article  PubMed  CAS  Google Scholar 

  40. Eda H, Fujimoto K, Watanabe S, Ufa M, Hino A, Tanaka Y, Wada K, Ishitsuka H (1993) Cytokines induce thymidine Phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluoridine. Cancer Chemother Pharmacol 32:333–338

    Article  PubMed  CAS  Google Scholar 

  41. Li J, Perrell MA, Tsai JC, Yet SF, Hsieh CM, Yoshizumi M, Patterson C, Endege WO, Zhou F, Lee M-E (1995) Induction of vascular endothelial growth factor gene expression by interleukin-1β in rat aortic smooth muscle cells. J Biol Chem 270:308–312

    Article  PubMed  CAS  Google Scholar 

  42. Kim KJ, Li B, Winer J, et al (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis supresses tumor growth in vivo. Nature 362:841

    Article  PubMed  CAS  Google Scholar 

  43. Asano M, Yukita A, Matsumoto T, et al (1995) Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor 121. Cancer Res 55:5296

    PubMed  CAS  Google Scholar 

  44. Takahashi Y, Nishioka K (1995) Survival without tumor shrinkage: reevaluation of survival gain by cytostatic effect of chemotherapy. J Natl Cancer Inst 87:1262–1263

    PubMed  CAS  Google Scholar 

  45. Nemunaitis J, Poole C, Primrose J, Rosemurgy A, Malfetano J, Brown P, Berrington A, Cornish A, Lynch K, Rasmussen H, Kerr D, Cox D, Millar A (1998) Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biological active and tolerable dose for longer-term studies. Clin Cancer Res 4:1101–1109

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Surgical Oncology, Cancer Research Institute, Kanazawa University, 4-86 Yoneizumi, Kanazawa, 921-8044, Japan

    Yutaka Takahashi & Masayoshi Mai

Authors
  1. Yutaka Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masayoshi Mai
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cancer Institute Hospital, 1-37-1 Kamiikebukuro, Toshima-ku, Tokyo, 170-8455, Japan

    Toshifusa Nakajima M.D., Ph.D. (Vice Director) (Vice Director)

  2. The First Department of Surgery, Kyoto Prefectural University of Medicine, Kawaramachi Hirokoji, Kamigyo-ku, Kyoto, 602-0841, Japan

    Toshiharu Yamaguchi M.D., Ph.D. (Associate Professor) (Associate Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Japan

About this chapter

Cite this chapter

Takahashi, Y., Mai, M. (1999). Angiogenesis and Angiogenic Factors of Gastric Cancer. In: Nakajima, T., Yamaguchi, T. (eds) Multimodality Therapy for Gastric Cancer. Springer, Tokyo. https://doi.org/10.1007/978-4-431-67927-1_24

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-67927-1_24

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-68009-3

  • Online ISBN: 978-4-431-67927-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation